LSV Asset Management Trims Holdings in Integer Holdings Corp (ITGR)

Share on StockTwits

LSV Asset Management reduced its stake in Integer Holdings Corp (NYSE:ITGR) by 66.1% during the first quarter, Holdings Channel reports. The fund owned 90,300 shares of the medical equipment provider’s stock after selling 176,131 shares during the quarter. LSV Asset Management’s holdings in Integer were worth $6,810,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Mason Street Advisors LLC boosted its stake in shares of Integer by 3.8% during the 1st quarter. Mason Street Advisors LLC now owns 9,608 shares of the medical equipment provider’s stock worth $725,000 after purchasing an additional 356 shares during the period. Everence Capital Management Inc. purchased a new position in shares of Integer during the 1st quarter worth about $312,000. Emerald Mutual Fund Advisers Trust boosted its stake in shares of Integer by 0.3% during the 1st quarter. Emerald Mutual Fund Advisers Trust now owns 328,396 shares of the medical equipment provider’s stock worth $24,768,000 after purchasing an additional 1,084 shares during the period. Optimum Investment Advisors purchased a new position in shares of Integer during the 1st quarter worth about $30,000. Finally, California Public Employees Retirement System boosted its stake in shares of Integer by 19.7% during the 1st quarter. California Public Employees Retirement System now owns 90,620 shares of the medical equipment provider’s stock worth $6,835,000 after purchasing an additional 14,944 shares during the period. Institutional investors own 94.25% of the company’s stock.

A number of equities analysts recently commented on the stock. Zacks Investment Research cut shares of Integer from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, April 24th. ValuEngine cut shares of Integer from a “buy” rating to a “hold” rating in a research note on Thursday, April 18th. Finally, Royal Bank of Canada lifted their price target on shares of Integer from $84.00 to $92.00 and gave the stock a “sector perform” rating in a research note on Monday, February 25th. Three equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. Integer currently has an average rating of “Buy” and an average price target of $89.40.

Integer stock opened at $68.81 on Friday. The stock has a market capitalization of $2.24 billion, a price-to-earnings ratio of 18.11 and a beta of 0.91. The company has a debt-to-equity ratio of 0.84, a current ratio of 2.55 and a quick ratio of 1.49. Integer Holdings Corp has a 1 year low of $62.80 and a 1 year high of $92.61.

Integer (NYSE:ITGR) last released its quarterly earnings data on Thursday, May 2nd. The medical equipment provider reported $1.00 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.80 by $0.20. The company had revenue of $314.70 million during the quarter, compared to analysts’ expectations of $302.29 million. Integer had a net margin of 14.67% and a return on equity of 13.37%. The firm’s quarterly revenue was up 7.6% on a year-over-year basis. During the same period in the previous year, the company earned $0.61 EPS. As a group, research analysts expect that Integer Holdings Corp will post 4.3 earnings per share for the current fiscal year.

In other Integer news, insider Jose Antonio Gonzalez sold 9,088 shares of the business’s stock in a transaction dated Thursday, February 28th. The shares were sold at an average price of $90.88, for a total value of $825,917.44. Following the completion of the sale, the insider now directly owns 11,899 shares of the company’s stock, valued at approximately $1,081,381.12. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, Director Donald J. Spence sold 50,559 shares of the business’s stock in a transaction dated Wednesday, March 13th. The shares were sold at an average price of $85.41, for a total transaction of $4,318,244.19. Following the completion of the sale, the director now directly owns 41,285 shares of the company’s stock, valued at $3,526,151.85. The disclosure for this sale can be found here. Over the last three months, insiders sold 62,147 shares of company stock valued at $5,358,962. 2.24% of the stock is owned by corporate insiders.

ILLEGAL ACTIVITY WARNING: This report was published by Ticker Report and is the sole property of of Ticker Report. If you are viewing this report on another publication, it was copied illegally and reposted in violation of international copyright & trademark legislation. The original version of this report can be read at https://www.tickerreport.com/banking-finance/4353294/lsv-asset-management-trims-holdings-in-integer-holdings-corp-itgr.html.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer worldwide. It operates in two segments, Medical and Non-Medical. The company offers products for vascular, cardiac surgery, and structural heart diseases; peripheral vascular, neurovascular, urology, and oncology products; and electrophysiology, infusion therapy, and hemodialysis products.

Read More: What is a put option?

Want to see what other hedge funds are holding ITGR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Integer Holdings Corp (NYSE:ITGR).

Institutional Ownership by Quarter for Integer (NYSE:ITGR)

Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Barry Zwarenstein Sells 7,663 Shares of Five9 Inc  Stock
Barry Zwarenstein Sells 7,663 Shares of Five9 Inc Stock
Venture Fund Vii L.P. Arch Sells 63,000 Shares of Syros Pharmaceuticals Inc  Stock
Venture Fund Vii L.P. Arch Sells 63,000 Shares of Syros Pharmaceuticals Inc Stock
Insider Selling: Neogen Co.  Director Sells 5,000 Shares of Stock
Insider Selling: Neogen Co. Director Sells 5,000 Shares of Stock
Neogen Co.  Director Sells $314,650.00 in Stock
Neogen Co. Director Sells $314,650.00 in Stock
Insider Selling: Airgain Inc  CEO Sells 22,464 Shares of Stock
Insider Selling: Airgain Inc CEO Sells 22,464 Shares of Stock
Insider Selling: Bottomline Technologies  Insider Sells 9,925 Shares of Stock
Insider Selling: Bottomline Technologies Insider Sells 9,925 Shares of Stock


© 2006-2019 Ticker Report